Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 13/20 | 0.60 |
| ▸ | PIK3CA | P42336 | 12/20 | 0.60 |
| ▸ | PIK3CB | P42338 | 12/20 | 0.60 |
| ▸ | PIK3CG | P48736 | 11/20 | 0.60 |
| ▸ | MTOR | P42345 | 1/20 | 0.60 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.53 |
| ▸ | KIT | P10721 | 2/20 | 0.44 |
| ▸ | BRAF | P15056 | 2/20 | 0.44 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.42 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.42 |
| ▸ | RAF1 | P04049 | 1/20 | 0.41 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.41 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL182967 | 0.88 | PIK3CA (0.68) | PIK3CDPIK3CAPIK3CBPIK3CGMTOR | |
| SCHEMBL183550 | 0.85 | PIK3CD (0.62) | PIK3CDPIK3CAPIK3CBPIK3CGMTOR | |
| SCHEMBL182818 | 0.84 | PIK3CD (0.67) | PIK3CDPIK3CAPIK3CBPIK3CGMTOR | |
| SCHEMBL182713 | 0.84 | PIK3CA (0.66) | PIK3CDPIK3CAPIK3CBPIK3CGMTOR | |
| SCHEMBL324075 | 0.84 | PIK3CD (0.54) | PIK3CDPIK3CAPIK3CBPIK3CGMTOR | |
| SCHEMBL182771 | 0.82 | PIK3CD (0.73) | PIK3CDPIK3CAPIK3CBPIK3CGMTOR | |
| SCHEMBL183062 | 0.81 | PIK3CD (0.59) | PIK3CDPIK3CAPIK3CBPIK3CGMTOR | |
| SCHEMBL183145 | 0.81 | PIK3CD (0.59) | PIK3CDPIK3CAPIK3CBPIK3CGMTOR | |
| SCHEMBL182536 | 0.81 | PIK3CA (0.60) | PIK3CDPIK3CAPIK3CBPIK3CGMTOR | |
| SCHEMBL182495 | 0.80 | PIK3CA (0.58) | PIK3CDPIK3CAPIK3CBPIK3CGMTOR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2049502-B1 | 2,4-SUBSTITUTED QUINAZOLINES AS LIPID KINASE INHIBITORS | NOVARTIS AG (CH) | 2012-01-04 | — | — | EP | claimed |